Urinary Arsenic Species and CKD in a Taiwanese Population: A Case-Control Study

American Journal of Kidney Diseases

Volumn 54, Issue 5, 2009, Pages 859-870

  Hsueh, Yu Mei ^a   Chung, Chi Jung ^a   Shiue, Horng Sheng ^a   Chen, Jin Bor ^b   Chiang, Shou Shan ^c   Yang, Mo Hsiung ^d   Tai, Cheng Wei ^a   Su, Chien Tien ^e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Arsenic; arsenic methylation capacity; chronic kidney disease; lycopene

Indexed keywords

ALPHA TOCOPHEROL; ANALGESIC AGENT; ARSENIC ACID; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; BETA CAROTENE; CACODYLIC ACID; LYCOPENE; METHANEARSONIC ACID; RETINOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METHYLATION; POPULATION RESEARCH; TAIWAN; URINALYSIS; URINE LEVEL;

ARSENIC; CAROTENOIDS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; METHYLATION; MIDDLE AGED; TAIWAN;

EID: 70350132295     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.06.016     Document Type: Article

References (43)

1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
2. Wen C.P., Cheng T.Y., Tsai M.K., et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 371 (2008) 2173-2182
3. US Renal Data System: USRDS 2007 Annual Data Report. http://www.usrds.org/ Accessed December 31, 2007
4. Haroun M.K., Jaar B.G., Hoffman S.C., et al. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 (2003) 2934-2941
5. Higashikuni Y., Ishizaka N., Ishizaka Y., et al. Relationship between blood pressure and chronic kidney disease in the Japanese population: The lower the better even in individuals without hypertension?. Hypertens Res 31 (2008) 213-219
6. Chen C.J., Kuo T.L., and Wu M.M. Arsenic and cancers. Lancet 1 (1988) 414-415
7. Pu Y.S., Yang S.M., Huang Y.K., et al. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol Appl Pharmacol 218 (2007) 99-106
8. Hong F., Jin T., and Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals 17 (2004) 573-580
9. Meliker J.R., Wahl R.L., Cameron L.L., et al. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: A standardized mortality ratio analysis. Environ Health 6 (2007) 4
10. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interact 88 (1993) 89-114
11. Aposhian H.V., Zakharyan R.A., Avram M.D., et al. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 198 (2004) 327-335
12. Aposhian H.V., and Aposhian M.M. Arsenic toxicology: Five questions. Chem Res Toxicol 19 (2006) 1-15
13. De C.S., Ghosh P., Sarma N., et al. Genetic variants associated with arsenic susceptibility: Study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes. Environ Health Perspect 116 (2008) 501-505
14. Kitchin K.T. Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172 (2001) 249-261
15. Schmuck E.M., Board P.G., Whitbread A.K., et al. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of omega class glutathione transferase variants: Implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases. Pharmacogenet Genomics 15 (2005) 493-501
16. Scibior A., and Zaporowska H. Effects of vanadium(V) and/or chromium(III) on l-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney. J Toxicol Environ Health A 70 (2007) 696-704
17. Nesnow S., Roop B.C., Lambert G., et al. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 15 (2002) 1627-1634
18. Stahl W., and Sies H. Antioxidant activity of carotenoids. Mol Aspects Med 24 (2003) 345-351
19. Augusti P.R., Conterato G.M., Somacal S., et al. Effect of lycopene on nephrotoxicity induced by mercuric chloride in rats. Basic Clin Pharmacol Toxicol 100 (2007) 398-402
20. Atessahin A., Ceribasi A.O., and Yilmaz S. Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin Pharmacol Toxicol 100 (2007) 372-376
21. Chen Y.C., Amarasiriwardena C.J., Hsueh Y.M., et al. Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol Biomarkers Prev 11 (2002) 1427-1433
22. Hsueh Y.M., Huang Y.L., Huang C.C., et al. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A 54 (1998) 431-444
23. Tseng C.H., Huang Y.K., Huang Y.L., et al. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206 (2005) 299-308
24. Miller K.W., Lorr N.A., and Yang C.S. Simultaneous determination of plasma retinol, alpha-tocopherol, lycopene, alpha-carotene, and beta-carotene by high-performance liquid chromatography. Anal Biochem 138 (1984) 340-345
25. Rothman K.J. Modern Epidemiology (1986), Little Brown, Boston, MA
26. Hosmer D.W., and Lemeshow S. Confidence interval estimation of interaction. Epidemiology 3 (1992) 452-456
27. Ratnaike R.N. Acute and chronic arsenic toxicity. Postgrad Med J 79 (2003) 391-396
28. Vanholder R., Cornelis R., Dhondt A., et al. The role of trace elements in uraemic toxicity. Nephrol Dial Transplant 17 suppl 2 (2002) S2-S8
29. Lewis D.R., Southwick J.W., Ouellet-Hellstrom R., et al. Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect 107 (1999) 359-365
30. Tsukamoto H., Parker H.R., Gribble D.H., et al. Nephrotoxicity of sodium arsenate in dogs. Am J Vet Res 44 (1983) 2324-2330
31. Prasad G.V., and Rossi N.F. Arsenic intoxication associated with tubulointerstitial nephritis. Am J Kidney Dis 26 (1995) 373-376
32. Fowler B.A. Mechanisms of kidney cell injury from metals. Environ Health Perspect 100 (1993) 57-63
33. Le X.C., Ma M., Cullen W.R., et al. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 108 (2000) 1015-1018
34. Mandal B.K., Ogra Y., and Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14 (2001) 371-378
35. Mass M.J., Tennant A., Roop B.C., et al. Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 14 (2001) 355-361
36. Petrick J.S., Ayala-Fierro F., Cullen W.R., et al. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163 (2000) 203-207
37. Zhang X., Cornelis R., De K.J., et al. Accumulation of arsenic species in serum of patients with chronic renal disease. Clin Chem 42 (1996) 1231-1237
38. Sasaki A., Oshima Y., and Fujimura A. An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp Hematol 35 (2007) 252-262
39. Sinha M., Manna P., and Sil P.C. Arjunolic acid attenuates arsenic-induced nephrotoxicity. Pathophysiology 15 (2008) 147-156
40. Chung C.J., Huang C.J., Pu Y.S., et al. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. Toxicol Appl Pharmacol 226 (2008) 14-21
41. Bongiovanni G.A., Soria E.A., and Eynard A.R. Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells. Food Chem Toxicol 45 (2007) 971-976
42. Hsueh Y.M., Wu W.L., Huang Y.L., et al. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 141 (1998) 249-257
43. Hsueh Y.M., Chiou H.Y., Huang Y.L., et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 589-596